Skip to main content
logo
NeoGenomics, Inc. (NEO)
NASDAQ: NEO · Real-Time Price · USD
19.21
+0.32 (1.69%)
Sep 16, 2026, 1:39 PM EDT - Market open

NeoGenomics Financials Overview

Millions USD. Fiscal year is Jan - Dec.

Revenue & Profits
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Revenue
766.3727.33660.57591.64509.73484.33
Revenue Growth
11.19%10.11%11.65%16.07%5.24%8.97%
Gross Profit
336.53313.89290.1244.6187.9187.06
Operating Income
-41.45-69.65-71.1-96.65-153.11-118.75
Net Income
-51.88-108.03-78.73-87.97-144.25-8.35
Earnings Per Share
-0.40-0.84-0.62-0.70-1.16-0.07
EPS Growth
------

Cash & Debt
Chart
Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Investments
145.54159.62386.84415.2437.99515.39
Total Debt
448.37409.46605.33611.68610.93612.79
Net Cash (Debt)
-302.83-249.84-218.49-196.48-172.94-97.4
Net Cash Growth
------
Net Cash Per Share
-2.35-1.95-1.73-1.57-1.39-0.81

Cash Flow & CapEx
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Cash Flow
22.055.237.02-1.95-65.99-26.72
Capital Expenditures
-29.4-27.01-41.06-28.75-30.89-64.14
Free Cash Flow
-7.36-21.78-34.04-30.71-96.88-90.87
Free Cash Flow Growth
------

Margins
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Gross Margin
43.92%43.16%43.92%41.34%36.86%38.62%
Operating Margin
-5.41%-9.57%-10.76%-16.34%-30.04%-24.52%
Pretax Margin
-7.12%-15.16%-12.21%-16.41%-31.26%-3.11%
Profit Margin
-6.77%-14.85%-11.92%-14.87%-28.30%-1.72%
FCF Margin
-0.96%-2.99%-5.15%-5.19%-19.01%-18.76%

Valuation
Chart
Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Forward PE
70.5983.58103.91266.98266.98266.98
PS Ratio
3.202.093.203.492.298.67